Klos KS - Search Results

1

Separating stem cells by flow cytometry: reducing variability for solid tissues.

Alexander CM, Puchalski J, Klos KS, Badders N, Ailles L, Kim CF, Dirks P, Smalley MJ. Alexander CM, et al. Among authors: klos ks. Cell Stem Cell. 2009 Dec 4;5(6):579-83. doi: 10.1016/j.stem.2009.11.008. Cell Stem Cell. 2009. PMID: 19951686 Free PMC article.

2

The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage.

Badders NM, Goel S, Clark RJ, Klos KS, Kim S, Bafico A, Lindvall C, Williams BO, Alexander CM. Badders NM, et al. Among authors: klos ks. PLoS One. 2009 Aug 12;4(8):e6594. doi: 10.1371/journal.pone.0006594. PLoS One. 2009. PMID: 19672307 Free PMC article.

3

Genotoxic exposure during juvenile growth of mammary gland depletes stem cell activity and inhibits Wnt signaling.

Klos KS, Kim S, Alexander CM. Klos KS, et al. PLoS One. 2012;7(11):e49902. doi: 10.1371/journal.pone.0049902. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185480 Free PMC article.

4

Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.

McDermott SP, Ranheim EA, Leatherberry VS, Khwaja SS, Klos KS, Alexander CM. McDermott SP, et al. Among authors: klos ks. Oncogene. 2007 Mar 1;26(10):1407-16. doi: 10.1038/sj.onc.1209930. Epub 2006 Sep 4. Oncogene. 2007. PMID: 16953225

5

Building bridges toward invasion: tumor promoter treatment induces a novel protein kinase C-dependent phenotype in MCF10A mammary cell acini.

Klos KS, Warmka JK, Drachenberg DM, Chang L, Luxton GW, Leung CT, Schwertfeger KL, Wattenberg EV. Klos KS, et al. PLoS One. 2014 Mar 5;9(3):e90722. doi: 10.1371/journal.pone.0090722. eCollection 2014. PLoS One. 2014. PMID: 24599099 Free PMC article.

6

Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.

Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D. Yao J, et al. Oncogene. 2001 Dec 6;20(56):8066-74. doi: 10.1038/sj.onc.1204944. Oncogene. 2001. PMID: 11781819

7

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, Hortobagyi GN, Hung MC, Yu D. Nagata Y, et al. Among authors: klos ks. Cancer Cell. 2004 Aug;6(2):117-27. doi: 10.1016/j.ccr.2004.06.022. Cancer Cell. 2004. PMID: 15324695 Free article.

8

ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.

Tan M, Li P, Klos KS, Lu J, Lan KH, Nagata Y, Fang D, Jing T, Yu D. Tan M, et al. Among authors: klos ks. Cancer Res. 2005 Mar 1;65(5):1858-67. doi: 10.1158/0008-5472.CAN-04-2353. Cancer Res. 2005. PMID: 15753384

9

ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.

Klos KS, Wyszomierski SL, Sun M, Tan M, Zhou X, Li P, Yang W, Yin G, Hittelman WN, Yu D. Klos KS, et al. Cancer Res. 2006 Feb 15;66(4):2028-37. doi: 10.1158/0008-5472.CAN-04-4559. Cancer Res. 2006. PMID: 16489002 Free article.

10

Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.

Lee S, Yang W, Lan KH, Sellappan S, Klos K, Hortobagyi G, Hung MC, Yu D. Lee S, et al. Cancer Res. 2002 Oct 15;62(20):5703-10. Cancer Res. 2002. PMID: 12384528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters